Startseite Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe
Artikel Open Access

Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe

  • Jun-Ying Song , Zi-Chuang Wang und Juan Zhang EMAIL logo
Veröffentlicht/Copyright: 29. September 2018

Abstract

C24H22N8O8ClFe, triclinic, P1̄ (no. 2), a = 10.4568(4) Å, b = 10.5977(4) Å, c = 12.0793(6) Å, α = 82.119(4)°, β = 83.277(4)°, γ = 87.206(3)°, Z = 2, V = 1316.11(9) Å3, Rgt(F) = 0.0565, wRref(F2) = 0.1609, T = 173(10) K.

CCDC no.: 1865960

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Brown cube
Size:0.40 × 0.20 × 0.10 mm
Wavelength:Cu Kα radiation (1.54184 Å)
μ:6.11 mm−1
Diffractometer, scan mode:SuperNova, ω
θmax, completeness:70.0°, 99%
N(hkl)measured, N(hkl)unique, Rint:8616, 4936, 0.048
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4310
N(param)refined:381
Programs:CrysAlisPRO [1], OLEX2 [2], SHELX [3], [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Fe10.47233(4)0.44331(4)0.27461(4)0.02041(17)
O10.6275(2)0.5249(2)0.21089(19)0.0276(5)
O20.7826(3)0.6853(3)0.0807(2)0.0468(7)
O30.3741(2)0.5990(2)0.29073(19)0.0264(5)
O40.3119(3)0.8236(2)0.3545(2)0.0344(6)
N10.4693(3)0.1274(3)0.0816(3)0.0344(7)
N20.5179(3)0.2576(3)0.2185(2)0.0249(5)
N30.4027(3)0.3376(3)0.0720(3)0.0343(7)
H30.37350.33360.00710.041*
N40.3861(3)0.4463(3)0.1234(2)0.0274(6)
N50.3177(3)0.2196(3)0.5844(3)0.0329(6)
N60.3371(3)0.3399(3)0.4000(2)0.0249(5)
N70.5050(3)0.3162(3)0.5079(2)0.0297(6)
H70.54070.28690.56920.036*
N80.5729(3)0.3888(3)0.4189(2)0.0243(5)
C10.2156(3)0.3109(3)0.3893(3)0.0304(7)
H10.18010.34130.32130.036*
C20.1418(4)0.2389(4)0.4732(3)0.0369(8)
H20.05580.21980.46510.044*
C30.1974(4)0.1947(4)0.5708(3)0.0341(8)
H3A0.14760.14470.63030.041*
C40.3817(3)0.2916(3)0.4977(3)0.0259(6)
C50.6923(3)0.4075(3)0.4293(3)0.0255(6)
H50.72550.36840.49610.031*
C60.7772(3)0.4818(3)0.3488(3)0.0261(6)
C70.9023(4)0.4978(4)0.3761(3)0.0339(8)
H7A0.92790.45520.44480.041*
C80.9872(4)0.5731(4)0.3058(4)0.0424(9)
H81.07190.58110.32460.051*
C90.9494(4)0.6386(4)0.2059(4)0.0428(9)
H91.00730.69410.15840.051*
C100.8279(4)0.6230(4)0.1756(3)0.0350(8)
C110.7404(3)0.5408(3)0.2444(3)0.0250(6)
C120.8610(6)0.7842(7)0.0182(5)0.086(2)
H12A0.81390.8309−0.04100.130*
H12B0.94080.7462−0.01590.130*
H12C0.88190.84300.06900.130*
C130.5836(3)0.1573(3)0.2692(3)0.0314(7)
H130.62470.16750.33350.038*
C140.5926(4)0.0412(4)0.2302(3)0.0363(8)
H140.6377−0.02940.26700.044*
C150.5339(4)0.0307(4)0.1357(4)0.0372(8)
H150.5396−0.04910.10760.045*
C160.4660(3)0.2367(3)0.1259(3)0.0284(7)
C170.3286(3)0.5428(3)0.0685(3)0.0297(7)
H170.30450.5332−0.00330.036*
C180.2996(3)0.6618(3)0.1094(3)0.0263(7)
C190.2387(4)0.7578(4)0.0379(3)0.0323(7)
H190.22340.7415−0.03480.039*
C200.2018(4)0.8721(4)0.0711(3)0.0353(8)
H200.16120.93510.02180.042*
C210.2234(4)0.8980(3)0.1782(3)0.0326(7)
H210.19620.97790.20180.039*
C220.2848(3)0.8066(3)0.2499(3)0.0266(7)
C230.3224(3)0.6854(3)0.2177(3)0.0235(6)
C240.2742(5)0.9434(4)0.3923(3)0.0417(9)
H24A0.31491.01230.33950.063*
H24B0.30140.94480.46700.063*
H24C0.18030.95520.39620.063*
Cl1−0.06798(9)0.14698(10)0.25431(8)0.0403(2)
O5−0.1315(4)0.2575(4)0.2010(3)0.0650(10)
O60.0664(3)0.1687(3)0.2515(3)0.0525(8)
O7−0.1251(4)0.1236(5)0.3686(3)0.0733(12)
O8−0.0846(4)0.0407(4)0.1951(4)0.0660(10)

Source of material

All starting materials are commercially available, and are used without further purification. 2-Hydrazinopyrimidine and 2-methoxy-6-(pyrimidin-2-ylhydrazonomethyl)-phenol (H2L) were prepared following reported procedures [5]. Perchlorate salts of metal complexes with organic ligands are potentially explosive and should be handled in small quantities with care.

The title compound [Fe(L)2]ClO4 was obtained according to the following procedure. 2-Methoxy-6-(pyrimidin-2-ylhydrazonomethyl)-phenol (0.1 mmol, 21.4 mg) was dissolved in the methanol (15 mL) under stirring, and then filtered to give a light yellow solution. Afterwards, Fe(ClO4)2⋅6 H2O (0.05 mmol, 18.1 mg) in deionized water (10 mL) was slowly diffused to the above solution in a sealed monotube. After several days, brown cube-shaped crystals were obtained. Yield: ca. 80%.

Experimental details

The H atoms were added using riding models. Their Uiso values were set to 1.2Ueq of the parent C and N atoms, and 1.5Ueq of the parent O atoms.

Comment

Pyrimidine derivatives are important pharmaceutical intermediates, because of the antitumor, bactericidal, and plant growth promoting properties [6], [7]. After coordination to metal ions, pyrimidine derivatives can not only enhance the activity of the original drugs but also reduce their toxicity and side effects [8]. Many Schiff bases have antibacterial and antitumor activities that can be enhanced after forming complexes with transition metals. The Schiff base complexes have strong cell penetration and fat solubility, which makes the antibacterial range of the complexes expand, and it is not easy to produce drug resistance [9], [10], [11], [12].

The title complex is a mononuclear iron(III) complex. The iron(III) ion in [Fe(L)2]+ is hexa-coordinated by four nitrogen atoms and two oxygen atoms from two ligands to form a N4O2 octahedral configuration. The Fe—N and Fe—O bond distances are in the range of 2.125(3)–2.182(3) Å, and 1.906(2)–1.921(2) Å, respectively. There is apparent intermolecular hydrogen bonding interaction between the methoxy oxygen and the amide H—N group (O2⋯N3 = 2.866(4) Å, O4⋯N7 = 2.901(4) Å). The hydrogen bonds link adjacent molecules into a 1D supramolecular chain structure.

Award Identifier / Grant number: U1504829

Funding statement: This work was supported by the National Natural Science Foundation of China (Project No. U1504829), the project of scientific and technological in Henan Province (Project No. 172102310433), the key scientific research project of colleges and universities in Henan Province (Project No. 16A350006) and the Provincial special Scientific Research Fund (Project No. 2014KYYWF-ZZCX3-06).

References

Agilent Technologies: CrysAlis PRO Software system, version 1.171.38.43f, Rigaku Oxford Diffraction (2015).Suche in Google Scholar

Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar

Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar

Yuan, J.; Chu, Y.-X.; Kou, H.-Z.: Synthesis, crystal structures and magnetic properties of methoxo-bridged dinuclear MnIII complexes derived from tri-dentate chelating ligands. J. Coord. Chem. 69 (2016) 1218–1225.10.1080/00958972.2016.1166217Suche in Google Scholar

Anneheim-Herbelin, G.; Perrèe-Fauvet, M.; Gaudemer, A.; Helissey, P.; Giorgi-Renault, S.: Porphyrin-netropsin: a potential ligand of DNA. Tetrahedron 34 (1993) 7263–7266.10.1016/S0040-4039(00)79304-XSuche in Google Scholar

Li, B.; Lin, B.-D.; Liu, C.-L.; Liu, W.-C.: Synthesis and fungicidal activities of 2-substituted amino-4,6-dichloropyrimidines. Chin. J. Synth. Chem. 4 (1996) 176–179.Suche in Google Scholar

Zhang, P.-Z.; Wu, J.; Gong, Y.-Q.: Synthesis and bioactivity of pyrimidine complexes with Cu(II) and Zn(II). Chin. J. Appl. Chem. 17 (2000) 558–560.Suche in Google Scholar

Liu, Y. C.; Yang, Z. Y.: Antioxidation and DNA-binding properties of binuclear Er(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carboxyaldehyde and four aroylhydrazides. Inorg. Chem. Commun. 12 (2009) 704–706.10.1016/j.inoche.2009.05.020Suche in Google Scholar

Creaven, B. S.; Duff, B.; Egan, D. A.; Kavanagh, K.; Rosair, G.; Thangella, V. R.; Walsh, M.: Anticancer and antifungal activity of copper(II) complexes of quinolin-2(1H)-one-derived Schiff bases. Inorg. Chim. Acta 363 (2010) 4048–4058.10.1016/j.ica.2010.08.009Suche in Google Scholar

Chakraborty, A.; Kumar, P.; Ghosh, K.; Roy, P.: Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action. Eur. J. Pharmacol. 647 (2010) 1–12.10.1016/j.ejphar.2010.08.003Suche in Google Scholar PubMed

Qiao, X.; Ma, Z. Y.; Xie, C. Z.; Xue, F.; Zhang, Y. W.; Xu, J. Y.; Qiang, Z. Y.; Lou, J. S.; Chen, G. J.; Yan, S. P.: Study on potential antitumor mechanism of a novel Schiff base copper(III) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity. J. Inorg. Biochem. 105 (2011) 728–737.10.1016/j.jinorgbio.2011.01.004Suche in Google Scholar PubMed

Received: 2018-08-24
Accepted: 2018-09-05
Published Online: 2018-09-29
Published in Print: 2018-12-19

©2018 Jun-Ying Song et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of bis(6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-diiodophenolato)-κ4N,N′,O,O′)cer(IV), C32H20CeI8N4O4
  3. Crystal structure of (6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato-κ2N,O))copper(II), C16H12Cl2CuN2O2
  4. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)samarium(III)], C26H18N2O9Sm
  5. Crystal structure of 1-{4-[(2-hydroxy-5-nitrobenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15N3O4
  6. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis(μ2-1-(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)trizinc(II), C44H38Zn3N4O12
  7. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)–bis(μ2–(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)tricobalt(II), C44H38Co3N4O12
  8. Crystal structure of poly[aqua(μ4-2,2′,2′′-nitrilotriacetato-κ6O1,O3,O5:O2:O4:O6)-yttrium(III)], C6H8NO7Y
  9. Crystal structure of catena-poly[bromido-(μ2-pyrazine-2-carboxylato-κ3N:N′,O)copper(II)], C10H6N4Cu2O4Br
  10. Crystal structure of poly[dodekais(μ2-2,6-difluorobenzoato-κ2O:O′)-bis((μ3-hexamethylenetetramine-κ3N:N′:N′′)hexacopper(II)], C48H30N4O12F12Cu3
  11. Crystal structure of methyl 4-(4-hydroxy-3-nitrophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C18H18N2O6
  12. Crystal structure of N-phenyl-2-(propan-2-ylidene)hydrazine-1-carbothioamide, C10H13N3S
  13. Crystal structure of sodium caesium zinc phosphate, NaCsZnP2O7
  14. Crystal structure of methyl 4-(4-isopropylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C23H29NO3
  15. Crystal structure of catena-poly[bis(μ2-1,3-di(4H-1,2,4-triazol-4-yl)benzene-κ2N:N′)-bis(thiocyanato-κ1N)cobalt(II), C22H16CoN14S2
  16. Crystal structure of catena-poly[(μ2-2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ2N:N′)-bis(2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ1N)-bis(thiocyanato-κ1N)cobalt(II)], C38H24CoN14S5
  17. Crystal structure of bis(2,5-di(pyridin-2-yl)-1,3,4-thiadiazole-κ2N,N′)-bis(thiocyanato-κ1N)cobalt(II), C26H16CoN10S4
  18. Crystal structure of (bis((1H-benzo[d]imidazol2-yl)methyl)amine-κ3N,N′,N′′)-(pyridine-2,6-dicarboxylato-κ3N,O,O′)zinc(II) — methanol — water (1/2/1), C25H28N6O7Zn
  19. Crystal structure of catena-poly[triaqua-(μ2-5-methoxy-isophthalato-κ2O:O′)copper(II)], C9H12CuO8
  20. Structure and photochromism of 1-[2-methyl-5-phenyl-3-thienyl]-2-[2-methyl-5-(4-chlorophenyl)-3-thienyl]3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16ClF6S2
  21. Crystal structure of methyl 4-(3-phenoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C26H27NO4
  22. Crystal structure of poly[diaqua-di-μ2-hydroxido-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ4O:O′:O′′:O′′′)-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ5O,O:O′:O′′:O′′′)disamarium(III)] – bipyridine (2/1), C21H11NF16O12Sm2
  23. Crystal structural of diethyl 4-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C19H21Br2NO5
  24. Crystal structure of catena-poly[tetraaqua(μ2-4-(1H-imidazol-1-yl)pyridine-κ2N:N′))zinc(II)] thiophene-2,5-dicarboxylate, C14H17N3O8ZnS
  25. Crystal structure of (20S)-20-(dimethylamino)-3-(tigloylamino)-5α-pregn-2,16-dien-4-one, C28H42N2O2
  26. Crystal structure of rac-trans-N,N′-bis(3,5-diiodosalicylidene)-1,2-cyclohexanediamine, C20H18I4N2O2
  27. Crystal structure of 2-bromo-7-(4-(dimethylamino)phenyl)-10-methylacridin-9 (10H)-one, C22H19BrN2O
  28. Crystal structure of catena-poly[(μ2-pentane-1,5-dicarboxylato-κ2O:O′)-(μ2-2-[(1H-imidazol-1-yl)methyl]-6-methyl-1H-benzimidazole-κ2N:N′)zinc(II)] sesquihydrate, C17H21N4O5.5Zn
  29. Crystal structure of ethyl 2-amino-4-(3,4-difluorophenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C21H15F2NO5
  30. Crystal structure of 9-(5-methylthiophen-2-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, C18H18O3S
  31. Crystal structure of [5,5′-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-2-ylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′]nickel(II), C23H30N4O4Ni
  32. Crystal structure of (Z)-2-(2-(1,3-dioxo-1-(phenylamino)butan-2-ylidene)hydrazineyl) terephthalic acid-dimethylsulfoxide (1/1), C18H15N3O6 ⋅ C2H6OS
  33. Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4
  34. Crystal structure of (2Z,2′Z)-1,1′-(pyridine-2,6-diyl) bis(3-hydroxy-3-phenylprop-2-en-1-one), C23H17NO4
  35. Crystal structure of ethyl 2-amino-4-(3-bromophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C21H16BrNO5
  36. Crystal structure of bis(μ2-3,5-dichloro-2-oxidobenzoato-κ4O,O′:O′,O′′)-hexakis(μ2-pivalato-κ2O:O′)-bis(pivalato-κ2O,O′)-tetrakis(1,10-phenanthroline-κ2N,N′)tetragadolinium(III), C102H108Cl4Gd4N8O22
  37. Crystal structure of catena-poly[aqua-bis(formato-κ1O)-(μ2-1,1′-(oxybis(1,4-phenylene))-bis(1H-1,2,4-triazole)-κ2N:N′)copper(II)]hydrate, C18H16CuN6O6
  38. Crystal structure of 5-bromo-2-(naphthalen-6-yl)pyridine, C15H10BrN
  39. Crystal structure of N-(4-methoxybenzyl)pyridazin-3-amine- a rare Z′ = 4 structure, C12H13N3O
  40. Crystal structure of bis(perchlorato-κ1O)-bis(3,4,5-trimethoxy-N-(pyridin-2-yl)benzamide-κ2N,O)copper(II), C32H30Cl2CuN4O16
  41. Crystal structure of methyl 4-methyl-2,5-di(pyridin-4-yl)-1H-pyrrole-3-carboxylate monohydrate C17H15N3O2⋅H2O
  42. Crystal structure of dimethyl 5-(10-(methoxycarbonyl)anthracen-9-yl) isophthalate,C26H20O6
  43. Crystal structure of tert-butyl (R)-(1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)carbamate, C16H24N2O4
  44. Crystal structure of aqua-bis(1,5-dimethyl-2-phenyl-4-(((E)-4-pyridylmethylene)amino)pyrazolidin-3-one-κN)-(nitrato-κO)-(nitrato-κ2O,O′)zinc(II), C34H34N10O9Zn
  45. Crystal structure of catena-poly[dichlorido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)cobalt(II)] – methanol (1/1), C18H20Cl2CoN4O2
  46. Crystal structure of poly[diaqua-bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)manganese(II)]bis(2-carboxybenzoate) dihydrate, MnC40H40N10O12
  47. The crystal structure of 4-((3,4-dichlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, C18H15Cl2N3O
  48. Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe
  49. The crystal structure of 2-[4-hydroxy-3-methoxyphenyl]-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl, C14H19N2O4
  50. Crystal structure of diaqua-bis(3,3-dimethylacrylato-κ2O,O′)zinc(II), C10H18ZnO6
  51. Crystal structure of dichloro-tetrakis[(E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol-κN]cadmium (II), C60H74CdCl6N12O4
  52. Crystal structure of (20R)-20,25-epoxy-dammaran-3,12-dione, C30H48O3
  53. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-((pyridin-2-ylmethylene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C32H31N5O2
  54. The crystal structure of 2-(4-fluorophenyl)-1,3,4-oxadiazole, C8H5FN2O
  55. Crystal structure of (2,2′-bipyridine-κ2N,N′)bis(tri(p-tolyl)phosphine-κP)copper(I) tetrafluoroborate – 4,4′-bipyridine (2/1), C57H54BCuF4N3P2
  56. The crystal structure of 2,6-dimethyl-3,5-dinitrocyclohexa-2,5-diene-1,4-dione, C8H6N2O6
  57. The crystal structure of 2,3-dimethyl-1,4-dinitrobenzene – a Z′ = 4 structure, C8H8N2O4
  58. Crystal structure of [(1,2-η)-1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl] (1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-κ6N2,O4) rubidium (I), [Rb(diaza-18-crown-6)]Cp*, C22H41N2O4Rb
  59. Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S
  60. Crystal structure of pyrene-4-aldehyde, C17H10O
  61. Crystal structure of 2-(furan-2-yl)-5-methyl-1,3-dioxane-5-carboxylic acid, C10H12O5
  62. Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl
  63. Crystal structure and photochromism of 1-(2-ethyl-5-formylthiophen-3yl)-2-(2-cyano-1,5-dimethyl-4-pyrrl)-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C19H14F6N2OS
  64. Crystal structure of 2-(4-bromophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16BrIN2
  65. Crystal structure of 2-(4-(dimethylamino)phenyl)-10-methylacridin-9(10H)-one, C22H20N2O
  66. Crystal structure of 4-(acetoxymethyl)-6-(3-acetyl-3-(4-fluorophenyl)thioureido)cyclohex-4-ene-1,2,3-triyl triacetate, C24H26FN2O9S
Heruntergeladen am 28.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0227/html
Button zum nach oben scrollen